Skip to main content

Table 2 Univariable and multivariable Cox regression model analyses of cause-specific survival in nomogram cohort

From: Prognostic nomograms for predicting cause-specific survival and overall survival of stage I–III colon cancer patients: a large population-based study

Variable

Univariable analysis

Multivariable analysis

HR

95% CI

P-value

HR

95% CI

P-value

Gender

  

0.002

  

0.066

 Female

1

  

1

  

 Male

0.909

0.857–0.965

 

1.058

0.965–1.054

 

Race

  

0.985

   

 White

1

     

 Othera

1.001

0.907–1.105

    

Year of diagnosis

  

0.445

   

 2010–2012

1

     

 2013–2015

0.976

0.915–1.040

    

Age at diagnosis

  

< 0.001

  

< 0.001

 < 60

1

  

1

  

 ≥ 60

1.913

1.781–2.056

 

1.718

1.591–1.856

 

Tumor site

  

< 0.001

  

0.003

 Right

1

  

1

  

 Left

0.825

0.778–0.875

 

0.912

0.857–0.970

 

Histological subtype

  

< 0.001

  

0.001

 AD

1

  

1

  

 MAD

1.251

1.135–1.378

< 0.001

0.983

0.891–1.085

0.738

 SRCC

4.042

3.368–4.851

< 0.001

1.444

1.195–1.746

< 0.001

Pathological grade

  

< 0.001

  

< 0.001

 Grade I

1

  

1

  

 Grade II

1.447

1.259–1.664

< 0.001

1.080

0.939–1.243

0.282

 Grade III

2.867

2.477–3.319

< 0.001

1.350

1.162–1.568

< 0.001

 Grade IV

3.704

3.091–4.439

< 0.001

1.650

1.372–1.984

< 0.001

T stage

  

< 0.001

  

< 0.001

 T1

1

  

1

  

 T2

2.022

1.590–2.573

< 0.001

1.741

1.366–2.218

< 0.001

 T3

5.497

4.429–6.822

< 0.001

3.579

2.864–4.472

< 0.001

 T4a

14.594

11.686–18.226

< 0.001

7.283

5.775–9.186

< 0.001

 T4b

17.479

13.929–21.933

< 0.001

9.477

7.467–12.029

< 0.001

N stage

  

< 0.001

  

< 0.001

 N0

1

  

1

  

 N1

2.418

2.257–2.591

< 0.001

2.090

1.774–2.461

< 0.001

 N2

4.679

4.437–5.125

< 0.001

3.220

2.678–3.872

< 0.001

Chemotherapy

  

< 0.001

  

< 0.001

 No

1

  

1

  

 Yes

1.142

1.076–1.213

 

0.498

0.465–0.534

 

LNH

  

< 0.001

  

< 0.001

 < 12

1

  

1

  

 ≥ 12

0.669

0.617–0.726

 

0.582

0.535–0.634

 

LODDS stage

  

< 0.001

  

< 0.001

 LODDS 1

1

  

1

  

 LODDS 2

2.689

2.528–2.861

< 0.001

1.290

1.097–1.517

0.002

 LODDS 3

7.359

6.64–8.156

< 0.001

2.005

1.647–2.442

< 0.001

 LODDS 4

21.948

16.814–28.649

< 0.001

4.274

3.109–5.876

< 0.001

Tumor size

  

< 0.001

  

0.038

 < 4

1

  

1

  

 ≥ 4

1.781

1.671–1.899

 

1.075

1.004–1.152

 

CEA

  

< 0.001

  

< 0.001

 Negative

1

  

1

  

 Positive

2.292

2.163–2.429

 

1.575

1.484–1.671

 

Marriage status

  

< 0.001

  

< 0.001

 Married

1

  

1

  

 Single

1.323

1.199–1.459

< 0.001

1.197

1.085–1.321

< 0.001

 Separated/Divorced

1.397

1.285–1.519

< 0.001

1.298

1.193–1.493

< 0.001

 Widowed

2.084

1.937–2.243

< 0.001

1.470

1.362–1.587

< 0.001

  1. HR hazard ratio, CI confidence interval, AD adenocarcinoma, MAD mucinous adenocarcinoma, SRCC signet ring cell carcinoma, LNH lymph nodes harvested, LODDS log of odds between the number of positive lymph node and the number of negative lymph node, CEA carcinoembryonic antigen, TNM tumor-node-metastasis
  2. aIncludes Black, Native American, Asian, Pacific Islander and Unknown